Have a personal or library account? Click to login
Myotonic dystrophy Type 1: exploring the health care experiences of people living with DM1. A Research Protocol Cover

Myotonic dystrophy Type 1: exploring the health care experiences of people living with DM1. A Research Protocol

Open Access
|Jul 2022

References

  1. Anderson, J., Tay, G., Robinson, P., Denby, G., Robinson, J., Douglas, J., & Curtin, D. (2018). Improving service delivery for neuromuscular diseases: a survey of consumers at a tertiary Australian hospital. Internal Medicine Journal, 48(12), 1520-1524. doi:10.1111/imj.14123
  2. Ashizawa, T., Gagnon, C., Groh, W. J., Gutmann, L., Johnson, N. E., Meola, G., . . . Winblad, S. (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract, 8(6), 507-520. doi:10.1212/cpj.0000000000000531
  3. Bandura, A. (1978). Self-efficacy: Toward a unifying theory of behavioral change. Advances in Behaviour Research and Therapy, 1(4), 139-161. doi:10.1016/0146-6402(78) 90002-4
  4. Boentert, M., Cao, M., Mass, D., De Mattia, E., Falcier, E., Goncalves, M., . . . Sansone, V. A. (2020). Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1. Respiration, 99(4), 360-368. doi:10.1159/000505634
  5. Bostrom, K., Ahlstrom, G., & Sunvisson, H. (2006). Being the next of kin of an adult person with muscular dystrophy. Clin Nurs Res, 15(2), 86-104; discussion 105-106. doi:10.1177/1054773805285706
  6. Chouinard, M. C. M., J.; Lavoic, M.; Leclerc, N.; Larouche, A.; Bouchard, N.; Jean, S.; Gagnon, C. (2008). User Guide: Integrated Care Pathway Tool for the Myotonic Dystrophy Type 1 (DM1-ICP). Retrieved from https://www.myotonic.org/sites/default/files/ICP_English%20version_final.pdf
  7. Creswell, J. W. (2013). Qualitative inquiry and research design: choosing among five approaches (3rd ed. ed.). Thousand Oaks, Calif.: SAGE Publications.
  8. Cup, E. H. C., Kinébanian, A., Satink, T., Pieterse, A. J., Hendricks, H. T., Oostendorp, R. A. B., . . . van Engelen, B. G. M. (2011). Living with myotonic dystrophy; what can be learned from couples? a qualitative study. BMC Neurol, 11. doi:10.1186/1471-2377-11-86
  9. De Antonio, M., Dogan, C., Hamroun, D., Mati, M., Zerrouki, S., Eymard, B., . . . Bassez, G. (2016). Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification. Revue Neurologique, 172 (10), 572-580. doi:https://doi.org/10.1016/j.neurol.2016.08.003
  10. Gagnon, C., Chouinard, M. C., Laberge, L., Veillette, S., Bégin, P., Breton, R., . . . Mathieu, J. (2010). Health supervision and anticipatory guidance in adult myotonic dystrophy type 1. Neuromuscular Disorders, 20 (12), 847-851. doi:https://doi.org/10.1016/j.nmd.2010.08.006
  11. Groh, W. J., Groh, M. R., Shen, C., Monckton, D. G., Bodkin, C. L., & Pascuzzi, R. M. (2011). Survival and CTG repeat expansion in adults with myotonic dystrophy type 1. Muscle & Nerve, 43(5), 648-651. doi:10.1002/mus.21934
  12. Hartley, S. E., Goodwin, P. C., & Goldbart, J. (2011). Experiences of attendance at a neuromuscular centre: perceptions of adults with neuromuscular disorders. Disabil Rehabil, 33 (12), 1022-1032. doi:10.3109/09638288.2010.520812
  13. Jansen, G., Mahadevan, M., Amemiya, C., Wormskamp, N., Segers, B., Hendriks, W., . . . et al. (1992). Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nat Genet, 1 (4), 261-266. doi:10.1038/ng0792-261
  14. LaDonna, K. A., Watling, C. J., Ray, S. L., Piechowicz, C., & Venance, S. L. (2017). Evolving Motivations: Patients’ and Caregivers’ Perceptions About Seeking Myotonic Dystrophy (DM1) and Huntington’s Disease Care. Qualitative Health Research, 27(11), 1727-1737. doi:10.1177/1049732317711901
  15. LaDonna, K. A., Watling, C. J., Ray, S. L., Piechowicz, C., & Venance, S. L. (2016). Myotonic Dystrophy and Huntington’s Disease Care: “We Like to Think We’re Making a Difference.” Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 43(5), 678-686. doi:10.1017/cjn.2016.257
  16. Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative research in psychology, 3(2), 77-101. doi:10.1191/1478088706qp063oa
  17. Laberge, L., Veillette, S., Mathieu, J., Auclair, J., & Perron, M. (2007). The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet, 71(1), 59-66. doi:10.1111/j.1399-0004.2007.00732.x
  18. Landfeldt, E., Nikolenko, N., Jimenez-Moreno, C., Cumming, S., Monckton, D. G., Faber, C. G., . . . Lochmüller, H. (2020). Activities of daily living in myotonic dystrophy type 1. Acta Neurol Scand, 141(5), 380-387. doi:10.1111/ane.13215
  19. Lecordier, D., Cartron, E., & Jovic, L. (2017). Comprendre les personnes atteintes de la maladie de Steinert pour mieux les soigner. Recherche en Soins Infirmiers, 131(4), 13-28. doi:10.3917/rsi.131.0013
  20. Magliano, L., & Politano, L. (2016). Family context in muscular dystrophies: psychosocial aspects and social integration. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 35(2), 96-99. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28344439 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343746/
  21. Malterud, K., Siersma, V. D., & Guassora, A. D. (2015). Sample Size in Qualitative Interview Studies: Guided by Information Power. Qualitative Health Research, 26(13), 1753-1760. doi:10.1177/1049732315617444
  22. Merleau-Ponty, M. 1945, (2013). Phenomenology of Perception. Florence:Taylor & Francis Group Routledge. http://myotonicdystrophy.com/http:/mytonicdystrophy.com/general-information/retrieved 06.11.2021
  23. Nätterlund, B., & Ahlström, G. (1999). Problem-focused coping and satisfaction with activities of daily living in individuals with muscular dystrophy and postpolio syndrome. Scand J Caring Sci, 13(1), 26-32.
  24. Peric, S., Vujnic, M., Dobricic, V., Marjanovic, A., Basta, I., Novakovic, I., . . . Rakocevic-Stojanovic, V. (2016). Five-year study of quality of life in myotonic dystrophy. Acta Neurol Scand, 134(5), 346-351. doi:10.1111/ane.12549
  25. Raymond, K., Levasseur, M., Mathieu, J., & Gagnon, C. (2019). Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1. Archives of Physical Medicine and Rehabilitation, 100(9), 1629-1639. doi:https://doi.org/10.1016/j.apmr.2019.01.022
  26. Raymond, K., Levasseur, M., Chouinard, M. C., Mathieu, J., & Gagnon, C. (2016). Stanford Chronic Disease Self-Management Program in myotonic dystrophy: new opportunities for occupational therapists: Stanford Chronic Disease Self-Management Program dans la dystrophie myotonique : De nouvelles opportunités pour les ergothérapeutes. Can J Occup Ther, 83(3), 166-176. doi:10.1177/0008417416646130
  27. Sandelowski, M. (1995). Sample size in qualitative research. Res Nurs Health, 18(2), 179-183. doi:10.1002/nur.4770180211
  28. Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., . . . Feigin, V. (2014). Prevalence of Muscular Dystrophies: A Systematic Literature Review. Neuroepidemiology, 43(3-4), 259-268. doi:10.1159/000369343
  29. Travlos, V., Bulsara, C., Patman, S., & Downs, J. (2016). A fine balance and a shared learning journey: Exploring healthcare engagement through the experiences of youth with Neuromuscular Disorders. NeuroRehabilitation, 39(4), 519-534. doi:10.3233/nre-161383
  30. Turner, C., & Hilton-Jones, D. (2010). The myotonic dystrophies: diagnosis and management. Journal of Neurology, Neurosurgery & Psychiatry, 81(4), 358-367. doi:10.1136/jnnp.2008.158261
  31. White, M. (2020). Patient Input to Inform the Development of Central Nervous System Outcome Measures in Myotonic Dystrophy. Ther Innov Regul Sci. doi:10.1007/s43441-020-00117-3
  32. Yang, B.-H., Chung, C.-Y., & Li, Y.-S. (2018). Partnership Between Families of Children with Muscular Dystrophy and Health-care Professionals: From Parents’ Perspective. Asian nursing research, 12(2), 127-135. doi:10.1016/j.anr.2018.05.002
DOI: https://doi.org/10.21307/ajon-2022-003 | Journal eISSN: 2208-6781 | Journal ISSN: 1032-335X
Language: English
Page range: 13 - 24
Published on: Jul 11, 2022
Published by: Australasian Neuroscience Nurses Association
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 Karen A O’Maley, published by Australasian Neuroscience Nurses Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.